FARALLON CAPITAL MANAGEMENT LLC - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$280,000
-95.4%
84,502
-91.5%
0.00%
-95.1%
Q4 2019$6,110,000
+81.4%
1,000,000
+23.8%
0.04%
+64.0%
Q3 2019$3,369,000
-66.1%
807,928
+6.7%
0.02%
-61.5%
Q2 2019$9,931,000–756,961–0.06%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders